TMB Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
TMB Capital Partners's BMY Position: Q2 2026 in Review
TMB Capital Partners increased its Bristol-Myers Squibb (BMY) stake by 0.27% in Q2 2026, buying an estimated $1.03K and bringing the position to 6,630 shares worth $382K. The position accounts for 0.12% of the portfolio, ranked #125.
TMB Capital Partners first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $401K in Q1 2026. 2,511 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- TMB Capital Partners held 6,630 shares of Bristol-Myers Squibb worth $382K as of Q2 2026.
- TMB Capital Partners bought 18 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.03K.
- Bristol-Myers Squibb made up 0.12% of TMB Capital Partners's portfolio in Q2 2026, its #125 holding.
- TMB Capital Partners first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- TMB Capital Partners's Bristol-Myers Squibb position peaked at $401K in Q1 2026.
- 2,511 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on TMB Capital Partners's 13F filing for Q2 2026, filed 24 Jul 2026.